EEntrepreneurship Read More New Life Sciences Fund and leadership churn reveal continued reset at BDCNovember 18, 2025 Growth Venture Fund leader is out nine months after BDC allocates $1 billion and expands mandate. The…
GGenetics Read More Congruence secures $32m in funds for genetic obesity drug trialSeptember 5, 2025 Congruence Therapeutics has completed a $32m funding round, earmarked for propelling its genetic obesity drug, CGX-926, into a…